Paraphlebitis

Paraphlebitis is an inflammatory disease of the venous wall, which can lead to serious complications and even death. The cause of the disease is an infection that enters the venous system through damaged skin or mucous membrane.

Paraphlebitis begins with pain in the affected area, often with a pulsating character. At this stage, redness and swelling may appear on the skin, which soon reach their peak.

Over the next few days, the skin begins to die, causing ulcers and subsequent fistula formation. If the disease is not treated promptly, it can penetrate deeper into the tissues covering fatty tissue and muscle, leading to purulent formations.

Complications of paraphlebitis can include the formation of paralytic stenoses, calcification of veins, phlebitis, sepsis and pulmonary embolism. Treatment of paraphlebitis requires surgery, antibiotic therapy and supportive care.

Paraphlebitis is a pathological condition that occurs as a result of inflammation of blood vessels or lymphatic vessels. This is a rare disease, occurring mainly in patients suffering from cardiovascular diseases and diabetes. Inflammation in tissue occurs due to blockage or stagnation of blood flow in adjacent veins.

Typically, paraphlebitis occurs against the background of viral diseases, but in some cases this is possible due to injuries or acute infections in the body, leading to disruption of the patency of blood vessels and vessels of the venous bed. The disease occurs as a secondary complication of thrombosis, atherosclerosis and syphilis. Symptoms of paraphlebitis can be quite varied - pain in the limb, redness and swelling of tissues, fever, severe itching and burning sensation, distension, throbbing pain with the release of purulent fluid. As a rule, the disease is complicated by sepsis. In particularly severe cases, surgery may be required to stabilize the patient's condition.

Patients with paraphlebitis are treated with antibiotics, as well as active infection control if necessary. Treatment is based on the prescription of drugs that prevent the development of inflammation and thrombosis. Due to the fact that the cause of the disease may be the presence of a viral infection, treatment requires an integrated approach and should be carried out by a general practitioner in collaboration with a cardiologist and a surgeon.

Disease